Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone
    Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone
    • News

  • Aerometrex Expands MetroMap Partner Program as Scalable Model Gains Traction
    Aerometrex Expands MetroMap Partner Program as Scalable Model Gains Traction
    • News

  • Middle East Conflict Starts to Hurt Corporate Earnings Outlooks
    Middle East Conflict Starts to Hurt Corporate Earnings Outlooks
    • News

  • European Lithium and Critical Metals Secure Control of Tanbreez Rare Earth Project
    European Lithium and Critical Metals Secure Control of Tanbreez Rare Earth Project
    • News

  • Harris Technology’s refurbished boom signals FY26 profit inflection
    Harris Technology’s refurbished boom signals FY26 profit inflection
    • News

December 2024 quarter CPI has interest rate doves cooing

  • In News
  • January 29, 2025
  • Tim Grey
December 2024 quarter CPI has interest rate doves cooing

Slightly below expectations December 2024 quarter CPI data released today were warmly received by stock market investors. The stats, which have ramifications for Australia’s monetary policy settings, bolstered hopes that the Reserve Bank of Australia (RBA) will reduce its benchmark interest rate ahead of the next Federal election, which must be held by May 2025. 

The odds on a lowering in the RBA’s benchmark rate, currently at 4.35%, at its next meeting on 18 February 2025 has definitely shortened, but it is still no certainty.

Why?

For one thing, key underlying CPI measures are still not quite within the RBA’s target range. For another, the RBA’s decision-making process is not solely determined by historical shifts in Australia’s main inflation indicator. It is also heavily influenced by inflation expectations, which is in turn impacted by a host of economic factors and variables, including the strength of our jobs market and the pace of spending by all levels of Australian government.

The headline CPI rose by 0.2% in the December 2024 quarter, a touch under market expectations of a 0.3% gain. This delivered an annual increase to 2.4%, which was below the 2.8% figure reported in the September 2024 quarter. The biggest quarterly gainers amongst the headline CPI’s components were Recreation and culture (+1.5%) and Alcohol and tobacco (+2.4%). On the flip side of the coin, a lid was kept on the latest headline CPI by falls in Housing (-0.7%) and Transport (-0.7%).

But what got the markets really excited was the reduced readings in the closely watched Trimmed Mean and Weighted Median underlying inflation measures included in the ABS CPI report. These are the inflation barometers given most attention by the RBA as it strives to deliver on its inflation charter, which is to keep annual underlying consumer price inflation between 2-3%.

The Trimmed Mean CPI was 0.5% in the December 2024 quarter, slightly below economists’ consensus forecast of 0.6%. The annual print of 3.2% was materially below the 3.6% number reported in the September quarter. Still not quite within the RBA’s target range, but definitely headed in the right direction for those pining for lower interest rates (holders of variable mortgages included).

An interesting new addition to the latest set of quarterly CPI stats was the inclusion of the items ‘trimmed’ out of the ABS’ Trimmed Mean CPI measure in the December 2024 quarter. The biggest decliner taken out was Electricity, which has declined appreciably of late thanks to Federal government Energy Bill Relief Fund rebates and State government rebates applied from July 2024 – these government initiatives effectively cut electricity costs for households in both the September and December 2024 quarters. The biggest gainer excluded from the December 2024 Trimmed Mean inflation measure was Eggs, a foodstuff currently experiencing significant supply shortages.

The good rally seen in Australian stock markets post the lower than expected December quarter CPI data was inevitable but does come with a potential sting in the tail for inflation – the improved CPI stats also generated some A$ selling, which, all other things being equal, adds to the price of imported goods.

But for now, a coop of interest doves (as well as a flock a government ministers!) are hoping the RBA is now much closer to an interest rate cut at its next meeting on 18 February, or failing that the following one on April Fools’ Day (how appropriate!)

  • About
  • Latest Posts
Tim Grey
Latest posts by Tim Grey (see all)
  • AML3D announces stronger FY26, with positive EBITDA reported in the second half - September 1, 2026
  • Imagion Biosystems Advances MagSense® Phase 2 Trial - August 27, 2026
  • Acrux-developed Menopause Hormone Therapy to enter Australian market - May 28, 2026
  •  
  •  
  •  
  •  
  • ABS
  • News

Leave a Comment

You must be logged in to post a comment.

1 Comment

  • Shraddha13
    February 4, 2025, 4:14 pm

    Thank you for sharing! To explore further
    https://www.360iresearch.com/library/intelligence/inflation-management-services

    Reply
  • About
  • Latest Posts
Tim Grey
Latest posts by Tim Grey (see all)
  • AML3D announces stronger FY26, with positive EBITDA reported in the second half - September 1, 2026
  • Imagion Biosystems Advances MagSense® Phase 2 Trial - August 27, 2026
  • Acrux-developed Menopause Hormone Therapy to enter Australian market - May 28, 2026

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Tim Grey
Latest posts by Tim Grey (see all)
  • AML3D announces stronger FY26, with positive EBITDA reported in the second half - September 1, 2026
  • Imagion Biosystems Advances MagSense® Phase 2 Trial - August 27, 2026
  • Acrux-developed Menopause Hormone Therapy to enter Australian market - May 28, 2026
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.